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Received 22 September 2015; revised 2 November 2015; accepted 5 November 2015AbstractIntegrity of the membranous labyrinth barrier system is of critical importance, which promotes inner ear homeostasis and maintains its
features. The membranous labyrinth barrier system is divided into several subsets of barriers which, although independent from each other, are
interrelated. The same substance may demonstrate different permeability characteristics through different barriers and under different conditions,
while different substances can have different permeability features even in the same barrier under the same condition. All parts of the mem-
branous labyrinth barrier structure, including their morphology, enzymes and channel proteins, and theirs permeability characteristics under
various physiological and pathological conditions are reviewed in this paper. Infections, noise exposure, ototoxicity may all increase perme-
ability of the barriers and lead to disturbances in inner ear homeostasis.
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Structures of biological barriers often control their perme-
ability and restrict penetrance of substances across the barrier
by various mechanisms to maintain stability in the barrier
environment. Such barriers especially serve to protect the
dynamic balance of inner ear fluids. Inner ear homeostasis
depends on the dynamic equilibrium of inner ear fluid secre-
tion and absorption involving inner ear blood supply, peri- and
endolymph, ion transport system and integrity of the mem-
branous labyrinth barrier system. The membranous labyrinth
is divide into different chambers by a barrier system, which
separates the endolymph, perilymph, cerebrospinal fluid (CSF)
and serum. Previous studies have proposed that membranous
labyrinth barriers are blood-labyrinth barriers (BLB), but
failed to clearly explain permeability characteristics of each
barrier (Hawkins, 1973; Juhn and Rybak, 1981; Ge, 1989;
Yamasoba et al., 1996a; Liu et al., 2013; Hirose et al., 2014;
Li et al., 2014; Wu et al., 2014; Zhang et al., 2015). In this
review, we propose that the so called BLB (or intra-ear fluid
barrier) consists of the bloodeendolymph barrier, blood-
eperilymph barrier, cerebrospinal fluideperilymph barrier,
middle earelabyrinth barrier and endolympheperilymph
barrier. All these barriers can be called membranous labyrinth
barriers. Each barrier permits penetrance by different sub-
stances, which can be employed to administrate drugs into the
inner ear.
2. Morphological basis of membranous labyrinth barriers2.1. Bloodeendolymph barrierThe bloodeendolymph barrier is seen in the stria vascu-
laris. Hawkins first proposed the concept of blood-labyrinth
barrier (BLB) in 1960 and re-emphasized the importance of
this barrier when he researched mechanisms of amino-
glycoside antibiotics induced ototoxicity in 1973 (Hawkins,
1973). He pointed out that functions of this barrier relied
on the integrity of the stria vascularis and spiral ligament (as
the stria vascularis, Reissner's membrane and spiral limbus
secrete endolymph), and also on the integrity of endolymph
spiral prominence, external sulcus, endolymphatic sac, which
absorb endolymph. Hawkins believed that aminoglycosides
induced pathological changes of the above mentioned struc-
tures, leading to disturbed endolymph secretion/absorption
balance, followed by dysfunction of the membranous laby-
rinth and protein synthesis and compromised inner ear ho-
meostasis, as the mechanisms of aminoglycoside ototoxicity.
Juhn and Rybak (1981) proposed that substances being
transported into the labyrinth may involve simple diffusion,
ultrafiltration, osmosis, lipid solubility, special tissue affinity
and metabolic activities of inner ear tissues. Sakagami et al.
(1984) found that, in the stria vascularis, endolymph barrier
structures constituted of tight junctions of marginal cells, and
perilymph barriers of tight junctions of basal cells. The space
between the two barriers is called the vascular space, which
is further sealed off by tight junctions of spindle cells at thejunction of the stria vascularis and vestibular membrane, as
well as at the spiral prominence. Zhang et al. (2012), Neng
et al. (2013a), Neng et al. (2013b) found large number of
perivascular-resident macrophage-like melanocytes (PVM/
Ms), perivascular cells and F4/80 þ GST þ melanocyte-like
macrophages inside the barrier space. Epithelium derived
factor (PEDF), a 50-kDa glycoprotein, is expressed in pri-
mary cultured PVM/Ms, and affects the expression of tight
junction associated proteins, whereas PEDF receptor
(PEDFR) is expressed in primary cultured endothelial cells
(ECs). Studies implicate PEDF signaling between PVM/Ms
and ECs as an important mediator of the effect PVM/Ms have
on expression of tight- and adherens-junction proteins such
as occludin, ZO-1 and ve-cadherin. Wu et al. (2014) indi-
cated that a large number of tight junction proteins (TJs),
including mainly Claudin-5 and Occludin, contributed to the
integrity and permeability of BLB by connecting adherens
proteins in pericytes and other TJs. Using rt-PCR and west-
ern blot, Neng et al. (2013a) found that signals secreted from
either pericytes or PVM/Ms had an effect on the expression
of TJs, directly linking pericytes and PVM/Ms with a
mechanism that accounts for the changes in endothelial
barrier permeability and increase of fluorescent antigen
exudation from EC monolayer. Weber et al. (2001) found that
Sodium-potassium-chloride cotransporter (NKCC) was pre-
sent in the basolateral membrane of strial marginal cells as
well as in type II, type V and limbal fibrocytes, which
maintain Kþ and Naþ homeostasis in the human cochlea.
Deficiency of NKCC leads to compromised endolymph
translation from marginal cells, reducing endolymph poten-
tial (EP) while increasing permeability of BLB which allows
more water molecules and other substances into endolymph,
resulting in endolymph hydrops. Yang et al. (2011) delin-
eated that 625 proteins from isolated stria vascularis capil-
laries were identified in adult CBA/CaJ mouse cochlea. Naþ/
Kþ-ATPase a1 (ATP1A1) is the most abundant protein in the
stria vascularis capillaries directly interacting with PKCg, an
essential mediator of ATP1A1-initiated occludin phosphory-
lation, and is involved in the integrity of the BLB. The
physiological and morphological basis of stria vascularis,
called “sandwich-dissociation”, is comprised of a dense
capillary network, indicating that endothelial cells, sur-
rounding pericytes, PVM/Ms, TJs, PEDF/PEDFR, NKCC,
ATP1A1 and PKCg kinase all participate in forming blood-
eendolymph barrier, which prevents some materials in blood
from entering endolymph while allows others to pass. The
permeability of this barrier, however, is very weak under
physiological conditions.2.2. Blood-perilymph barrierBy testing penetration of [3H] taurine (molecular weight
125) into the scala vestibule perilymph (PLV) at 1 and 2 h
after intravenous infusion in nephrectomized animals,
Angelini et al. (1998) found that bloodeperilymph barrier
was similar to bloodebrain barrier. They concluded that there
was a passive entry of taurine (as a tracer) into the perilymph
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weight 60) and mannitol (molecular weight 186) reported
previously in rats. Laurell et al. (2008) evaluated function of
bloodeperilymph barrier and found no increased perme-
ability for the used tracer mannitol, which is a low molecular-
weight marker (182 Da) of paracellular transport and readily
transported to the perilymphatic compartment, and no effect
on the concentration of Kþ and Naþ of the PLV by exposure
to impulse noise of 160 db SPLpeak. But they did not describe
the constituent of blood-perilymph barrier. The spiral liga-
ment, spiral limbus, modiolus and osseous spiral lamina
participate in forming the blood-perilymph barrier rather than
a single semipermeable membrane (Hirose et al., 2014).
Studies have found that this barrier allows penetration of
taurine, urea, mannitol, cationic polyethyleneimine (PEI),
tetramethylphenylammonium (TMPA), steroid hormones,
ototoxic drugs and lipopolysaccharides (LPS) into the PLV
(Zhang et al., 2015; Angelini et al., 1998; Laurell et al., 2008;
Suzuki et al., 2002).2.3. Cerebrospinal fluideperilymph barrierThe cerebrospinal fluideperilymph barrier consists of the
cochlear aqueduct, which connects cerebrospinal fluid (CSF)
of the subarachnoid space to perilymph of the scala tympani
and provides the possibility of interrelation between the two
fluid-containing compartments. Juhn et al. (1989) investigated
distribution and metabolism of leukotriene C4 (TLC4), which
can be metabolized into LTD4 and LTE4 in the CSF, and
found that LTE4 was transported into blood for systemic cir-
culation and uptake into the liver and kidneys. Conversion of
LTC4 into LTD4 and LTE4 was lower in the perilymph as
compared to the CSF, suggesting a rate limiting function of the
cochlear aqueduct that can be defined as a cerebrospinal flu-
idelabyrinth barrier. Salt et al. (2015) studied reduction of
dextran concentration caused by dilution from CSF entering
the cochlea at a very low rate of flow (~30 nL/min) when the
cochlea was in its normal, sealed state and confirmed that this
is an important process that can have a major influence on the
pharmacokinetics of some substances in the perilymph in the
basal turn of scala tympanic. Transport of substances such as
urea and hypertonic sodium chloride solution from CSF to
perilymph are related to the pressure and osmolality on both
sides of the barrier, which may have little influence on peri-
lymph under physiological conditions.2.4. Middle eareperilymph barrierThe middle eareperilymph barrier is a semipermeable
membrane called round window membrane (RWM), which
can be divided into three layers at a total thickness of about
0.7 um. The outer and the inner layers are made up of
epithelial cells while the middle layer of connective tissue
containing vascular and nerve fibers. Glycerol monooleate-
based nanoparticles (GMO-based NPs) and cationic ferritin
are found to pass quite easily through the normal RWM, but
not anionic materials (Goycoolea and Lundman, 1997; Parkand Moon, 2014). Nanoparticles as gene delivery vectors
may be used to transport drugs to targeted inner ear cells in
gene therapy for sensorineural deafness. Small molecular
weight substances such as sterols, aminoglycoside antibiotics,
1 m latex microspheres can pass through RWM under physi-
ological conditions, but high molecular substances such as
albumin (molecular weight 67,000) can only penetrate
inflamed RWM (Goycoolea and Lundman, 1997; Park and
Moon, 2014; Matsubara et al., 2014). Large amount of
eosinophil infiltration in the scala tympani has been found 28
days after ovalbumin (VOA) is injected into the tympanic
cavity. Leukotrienes (LTs) such as LTC4/LTB4 can penetrate
RWM, leading to dilation of capillaries (Park and Moon,
2014; Matsubara et al., 2014). Sasa et al. (1989) found that
pure oxygen, insufflated into the middle ear cavity, easily
permeated the round window membrane and elevated peril-
ymphatic oxygen tension by 319%. Salt and Ma (2001)
studied substance penetration through the RWM to the scala
tympani perilymph, and noticed a substance concentration
gradient from the bottom to helicotrema of the cochlea.
Ghossaini et al. (2013) used golimumab, a TNF-a blocker, as
a local delivery into the inner ear to assess the RWM
permeability in guinea pigs. They found that golimumab
crosses the RWM and is detected in measurable concentra-
tions in the inner ear fluid after 30 min of exposure to the
membrane, but can't explain its pharmacokinetics and optimal
concentration. The liposomes are considered to be most
successful drug-carrier system to deliver drugs into inner ear
(Bozzuto and Molinari, 2015; El et al., 2015). A variety of
substances placed in the middle ear, including antibiotics,
local anesthetics, tracers such as cationic ferritin, horseradish
peroxidase, sterols, GMO-based NPs, golimumab, pure oxy-
gen and 1 m latex microspheres, can be detected across the
RWM. Selective permeability of the RWM is determined by
factors including the size, concentration, liposolubility and
electrical charge of the substance, as well as the thickness of
the membrane.2.5. Endolympheperilymph barrierEpithelial cells of the Reissner membrane (RM) form the
endolympheperilymph barrier. The RM is located between the
scala vestibule (SV) and scala tympani (ST) and attached to
the osseous spiral lamina at the upper boundary of the stria
vascularis. Epithelial cells facing the endolymph come from
the ectoderm, have irregular shapes and a smooth surface, are
arranged in a tight pattern, and show high levels of ATP-ase
activities. Epithelial cells facing the perilymph come from
the mesoderm, are flat in shape and contain oval nuclei.
Scanning electron microscopy shows that on both sides of the
membrane, there are microvilli on cell surfaces and pinocy-
tosis vesicles in cytoplasm, indicating that RM participates in
regulation of ionic equilibrium in the endolymph and peri-
lymph. Using patch-clamp technique, Yeh et al. (1997) found
three types of ion channels on the apical membrane of
epithelial cells facing the endolymph in isolated Reissner's
membranes from guinea pigs, namely, stretch-activated
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channels. Immunolabeling shows that aquaporins (AQPs), i.e.
AQP2, AQP7 and AQP9, are expressed in Reissner's mem-
brane. They may work in concert to regulate endolymph
electrochemical equilibrium and maintain homeostasis in the
inner ear (Zhong and Liu, 2003; Huang et al., 2002).
3. Clinical significances of membranous labyrinth
barriers3.1. Noise exposureNoise exposure (NE) is a major health hazard in modern
time and can induce hearing impairment. Noise-induced ul-
trastructural changes of membranous labyrinth barriers lead to
NE-dependent hearing impairment. In 1971, Hawkins
(Hawkins, 1971) found that noise-induced hearing impairment
was related with edema of stria vascularis and spiral ligament,
vasoconstriction and aggregation of erythrocytes. By exam-
ining systemically administered cationic polyethyleneimine
(PEI), Mitsuya et al. (Suzuki et al., 2002) showed that noise
exposure increased macromolecular transport in the stria
vascularis but not in the spiral ligament, spiral limbus or
basilar membrane and that some macromolecules were readily
transported through Reissner's membrane. They suggested that
NE might increase transport of PEI particles through the basal
lamina (BL) of Reissner's membrane. There are two possible
routes of access to the BL of Reissner's membrane from the
strial vessels: (1) through the epithelial cell surface of Reiss-
ner's membrane via the endolymph, and (2) through the su-
perior portion of the stria vascularis at the point of attachment
to Reissner's membrane. This finding suggests that an increase
in strial vascularis permeability, induced by NE, may not result
in increased accumulation of PEI particles in the endolymph.
Wu et al. (2014) suggested that a dose-dependent NE caused a
decrease of Claudin-5 and Occludin, significant outer hair cell
(OHC) loss and increased permeability of membranous laby-
rinth barriers. Transport of cationic ototoxic drugs such as
aminoglycoside and platinum from strial vascularis to cochlear
tissues and OHCs is also accelerated (in both time and
quantity), proportional to concentrations of the drug. But
Laurell et al.'s findings (Laurell et al., 2008) through esti-
mating paracellular transport of radioactive mannitol into scala
vestibule perilymph (PLV) and electrolyte concentrations in
perilymph contradicted the theory of increased permeability of
the BLB as a result of extensive noise exposure. However, in
most cases, noise exposure can induce hearing impairment of
various degrees.3.2. InfectionsLipopolysaccharide (LPS), an important component of
bacterial endotoxin seen in Gram-negative bacterial in-
fections, increases permeability of membranous labyrinth
barriers because it can penetrate the RWM to appear in
perilymph and cause nitric oxide synthase expression that
leads to loss of TJs, disrupted continuity of ECs andinfiltration of inflammatory cells and factors in the strial
vascularis and spiral ligament. Zhang et al. (2015) showed
that LPS not only induced middle ear infections, but also
caused structural changes in the intra-strial fluideblood bar-
rier. Damage to this barrier has been linked to NE-dependent
hearing impairment, autoimmune inner ear disease, presby-
cusis and gene-related inner ear diseases. Pathogenic mecha-
nisms related to LPS may include: 1) effects on PCs and
PVM/Ms in the barrier, causing PCs to migrate and release
particles, as well as activation of PVM/Ms; and 2) significant
down-regulation of ZO-1, occludin, and ve-cadherin expres-
sion, subsequently leading to barrier leakage. Virus infections
can also lead to inner diseases. In mice infected with murine
cytomegalovirus (MCMV) and showing hearing loss, distri-
bution of tumor necrosis factor (TNF)-a, interleukin (IL)-6
and lymphocytes increase in the scala tympani and Reissner's
membrane (Yuehua et al., 2012). Infection of MCMV results
in hyperemia of strial vascularis and spiral ligament and
hemorrhage of ST and SV (Yuehua et al., 2012; Li et al.,
2014). Studies suggest that bacterial and viral infections not
only lead to systemic inflammatory reactions but also inner
ear diseases, especially hearing loss. These findings mandate
use of medications that target the pathogen with effective
penetration into the inner ear and low possibility of ototoxicity
when treating infections.3.3. DrugsOtotoxic drugs can enter the inner ear and cause damage to
membranous labyrinth barriers, leading to hearing impairment
and vestibular dysfunction as a result of toxicity to hair cells of
the cochlea and vestibular organs. Tatsuya Yamasoba et al.
(1996b) suggested that chronically administered kanamycin
(cationic tracer) could selectively, progressively and irrevers-
ibly affect anionic sites in the stria vascularis and basilar
membrane near the spiral limbus, resulting in disruption of
barrier function in the cochlea. Keiko Hirose et al. (2014)
found that LPS-pretreated mice showed greater long term
auditory threshold shifts and more extensive outer hair cell
loss following combined kanamycin-furosemide treatment
when compared with animals receiving ototoxic agents alone.
Changes in vascular permeability within the inner ear may
play a critical role in LPS-induced exacerbation of ototoxicity
and further studies are necessary to explore this possibility.
Takehisa Saito et al. (1997) reported P-glycoprotein (P-gp), a
multidrug resistance (mdr) gene product found in multidrug-
resistant tumor cells, expressing in inner ear capillary endo-
thelial cells that might play an important role in the blood-
einner ear barrier by acting as an extrusion pump that
prevents many substances such as aminoglycoside and anti-
tumor drugs from entering the inner ear. Expression of P-gp
is low in the mdr1a (yry) mouse and the absence of P-gp re-
sults in elevated drugs (adriamycin and vincristine) levels in
many tissues leading to endolymphatic sac dysfunction and
impaired endolymphatic absorption, and eventually endolym-
phatic hydrops. Liu et al. (2013) investigated the impact of
lead (Pb2þ) on the auditory system including ABR thresholds
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ZO-1 and claudin-5 in the stria vascularis suggested that
increased permeability of the bloodeendolymph barrier could
attribute to Pb2þ-induced decline of TJPs expression. But Wu
et al. (2011) found that lead primarily damages cochlear nerve
fibers and SGN rather than hair cells. Di et al. (2011) studied
that styrene ototoxicity in animals mainly disrupt cochlear
cells (outer hair cells). Further studies about whether if styrene
damage inner ear barrier or not, it will be investigated. Long
time accumulation and impaired expulsion of ototoxic drugs in
the inner ear can cause damage to inner ear membranous
labyrinth barriers via a variety of mechanisms. Understanding
of these mechanisms may guide clinical practice, so prolonged
use of combination of potentially ototoxic drugs can be
avoided, ototoxic side effects of drug treatment monitored, and
appropriate measures taken promptly when indicated.
Osmotic diuretics can enter the inner ear by various
mechanisms and have different effects on the inner ear. Juhn
and Rybak (1981) in an animal study found that injected os-
motic agents, glycerol and urea, appeared in the perilymph to a
considerable degree. Using ferritin as a tracer, Ge (1989)
showed that glycerol could serve as an opener of blood-
labyrinth barriers. However, mannitol injection resulted in
unexpected findings, i.e. perilymph osmolality remained
higher than that of the serum, suggesting that mannitol did not
have any effect of drawing water from the labyrinth into the
blood. Also, the magnitude and duration of the partial oxygen
pressure increase in perilymph have been found to be larger
after administration of glycerol than after that of mannitol
(Yoshida and Uemura, 1991). These results correspond well
with the clinical experience that glycerol is more effective than
mannitol in improving hearing in Meniere's disease (MD). The
concentration of furosemide, an ototoxic diuretic, measured by
high pressure liquid chromatography, is fairly constant at the
time of full recovery of EP after doses of 50e200 mg/kg (Juhn
and Rybak, 1981). Kim et al. (2014) found that isosorbide,
small in size (0.76 nm in diameter) and light in molecular
weight (146.14 g/mol), rapidly passed through the RWM after
round window perfusion (RWP) in guinea pigs. Perfusion of
30 min is considered to be appropriate and, over a 6-h period,
delivers the agent at 7 times higher concentrations than those
achieved with oral administration. Therefore, local application
of isosorbide, which can deliver high dose without systemic
adverse effects, is considered to be promising for the treatment
of MD. Osmotic diuretics can pass through the blood-
eendolymph barrier and/or middle eareperilymph barrier to
perilymph but not endolymph, as shown by some studies.
More investigations should analyze their base-to-apex con-
centration gradients through the entire perilymph and the time
course and durations of their actions. Further studies are also
needed to study their concentrations not only in perilymph, but
also in endolymph and serum.
Steroids can reduce inflammation, immune over-reaction
and edema and improve microcirculation in the inner ear.
They are widely used in the treatment of inner ear diseases.
However, long-term oral steroids are known to carry systemic
side effects. Local application of drugs may increase theirconcentrations in the inner ear and greatly reduce their sys-
temic side effects. Bachmann et al. (2001) demonstrated that
high levels of prednisolone-21-hydrogen succinate in peri-
lymph were achievable by local application of a single dose
into the round window niche than by intraperitoneal injection.
Applying steroids to treat cochleovestibular disorders, such as
sudden hearing loss, is a common clinical practice, with
various clinical efficacy and side-effect profiles. Novel drug
delivery techniques such as the Silverstein MicroWick, round
window microcatheter, biodegradable hydrogels, biopolymers,
nanoparticles, cochlear implant arrays, osmotic mini/micro
pumps, and reciprocating perfusion systems hold significant
promise. These sustained delivery systems provide more
effective inner ear pharmacokinetics than systemic adminis-
tration by animal data.
4. Conclusions
Each part of the membranous labyrinth barriers has
different functional and morphological bases, and demon-
strates variable permeability to different substances under
various physiological and pathological conditions. Under
physiological conditions, permeability of the blood-
endolymph barrier is low and allows passage of only a small
amount of water molecules, Naþ, Kþ, Cl, and ototoxic drugs.
Water molecules, steroids, osmotic diuretics (such as glycerin,
mannitol and isosorbide) and some ototoxic drugs (such as
aminoglycoside antibiotics, platinum antitumor drugs and
furosemide) can pass through the bloodeperilymph barrier,
although its permeability is less than that of the middle ear-
eperilymph barrier which also allows passage of horseradish
peroxidase, cationic ferritin, and 1 mm latex microspheres.
Substances in the CSF, including certain ions, proteins and
leukotrienes, can pass through the CSF-perilymph barrier. The
endolymph-perilymph barrier allows penetration by water
molecules and steroids but not ototoxic drugs or osmotic di-
uretics (such as glycerin, mannitol and isosorbide). Under
pathological conditions, the permeability of most of these
barriers increases, although the RWM can be thickened by
chronic inflammation resulting in decreased permeability.
Combination of some drugs may increase their penetration
through membranous labyrinth barriers, leading to potentially
enhanced passage of therapeutic drugs into the inner ear but
also increased ototoxicity. Inner ear barriers deserve further
assessment of their structures and functions for potential
clinical significances.
In this review, we have proposed the concept of distinct
labyrinth membranous barriers and described characteristics of
their permeability, which can influence functional homeostasis
and drug distributions in the inner ear. Pharmacokinetics of
various drugs in the inner ear in relation to continuous delivery
systems need to be studied in animal models for potential
clinical applications that may provide improved treatment
efficacy and reduced adverse effects. Models of drug delivery
systems for inner ear diseases such as sensorineural hearing
loss, tinnitus and vestibular disorders are forthcoming and will
guide practice and research into a brand new age for otology.
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